NSE
BSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Revenue and bed capacity are expanding, but rising costs and debt are squeezing profit margins.
Total income grew from ₹347.6 Cr in Q1 FY26 to ₹411.0 Cr in Q1 FY27, demonstrating steady revenue expansion.
PAT margin fell from 14.6% in Q2 FY26 to 9.1% in Q1 FY27, reflecting bottom-line pressure.
Bed capacity expanded from 1,061 in Q1 FY26 to 1,259 in Q1 FY27, supporting future patient volume.
Employee cost rose from ₹59.4 Cr in Q1 FY26 to ₹74.5 Cr in Q1 FY27, highlighting wage inflation.
Inpatient income rebounded from ₹286.7 Cr in Q3 FY26 to ₹320.0 Cr in Q1 FY27, confirming service demand recovery.
Finance cost spiked from ₹7.5 Cr in Q3 FY26 to ₹12.9 Cr in Q1 FY27, signaling increased debt burden.
Gross profit climbed from ₹279.3 Cr in Q1 FY26 to ₹331.0 Cr in Q1 FY27, maintaining strong pricing power.
EBITDA margin dropped from 23.4% in Q2 FY26 to 19.3% in Q1 FY27, indicating cost absorption challenges.
